CovidVax show full list
COVID-19 VACCINE:

Adeno-based

researcher:
Gamaleya Research Institute
http://www.istc.int/en/institute/8333
(Russia)
vaccine type: Non-replicating viral vector
Distribution updates
Jul 16Russia plans to domestically produce 30m doses of Gamaleya's vaccine this year (by reuters.com)
Human Testing updates (clinical trials)

PHASE 1-2

 

started June 17 2020

with 38 healthy volunteers aged 18-60

trial location: Moscow, Russia

» clinical trial details

PHASE 3 (Belarus)

 

started September 28 2020

with 100 healthy volunteers aged 18-60

trial location: Minsk, Belarus

» clinical trial details

PHASE 3 (Russia)

 

started August 31 2020

with 40000 healthy volunteers 18+

trial location: Moscow, Russia

» clinical trial details

Sep 20Over 60000 people have applied to volunteer for Sputnik V's trials in Moscow (by tass.com)
Sep 07Gamaleya Institute's Sputnik V is about to start its Phase 3 clinical trials with first volunteers (by tass.com)
Sep 04RDIF and Gamaleya Institute published a scientific article on the results of Phase 1/2 clinical trials (by thelancet.com)
Sep 01Gamaleya's vaccine will be distributed among Moscow outpatients clinics on Sep 3-4 (by tass.com)
Aug 26RDIF, Moscow's government and Gamaleya announced the start of a post-registration clinical trial (by rdif.ru)
Aug 11Russia became the first country to grant regulatory approval to vaccine developed by Gamaleya (by reuters.com)
Jul 16Gamaleya's first clinical trial reported positive results by inducing animmune response (by clinicaltrialsarena.com)
Jun 18Gamaleya's vaccine is being tested by Russia which started a national clinical trial of it (by trialsitenews.com)
Animal Testing updates (pre-clinical trials)
currently no pre-clinical trials info
early development updates
currently no early development info



funding:
Russian Direct Investment Fund (RDIF)



contact | about | ©2020 CovidVax.org project